Form 4: Ironwood Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

John Minardo, Chief Legal Officer of Ironwood Pharmaceuticals, sold 17,404 shares of Class A Common Stock to cover tax withholding obligations related to vesting of performance-based restricted stock units.

Summary

• On May 20, 2024, John Minardo, the Chief Legal Officer of Ironwood Pharmaceuticals, sold 17,404 shares of Class A Common Stock.
• The sale was executed at a price of $6.45 per share.
• This transaction was conducted to cover tax withholding obligations associated with the vesting of performance-based restricted stock units.
• Following the transaction, Minardo directly owns 294,571 shares of Ironwood Pharmaceuticals.
• The sale was not a discretionary trade but an automatic sell to cover transaction to satisfy tax obligations.

Sentiment

Score: 6

Explanation: The document is a routine SEC filing related to an executive's share sale for tax purposes. It doesn't indicate any significant positive or negative sentiment regarding the company's performance or outlook.

Industry Context

Executive share sales to cover tax obligations are a common practice and do not necessarily indicate a negative outlook for the company.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units that vest over time.
• Upon vesting, these units are subject to income tax, and executives often sell a portion of the shares to cover these tax obligations.
• This practice is common across various industries and companies, including pharmaceutical firms like Amgen, Gilead Sciences, and Biogen.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates